Back
Day One Biopharmaceuticals Inc (DAWN)
BiotechnologyDAWN · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$21.52
+0.14%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$-1.04
ROE
-22.7%
Gross margin
89.1%
Debt/Equity
0.63x
Revenue growth
83.9%
Day One Biopharmaceuticals Inc — company intelligence
Earnings surprises
Q4 2025$-0.21 vs $-0.15 est-35.6%
Q3 2025$-0.19 vs $-0.30 est+36.4%
Q2 2025$-0.29 vs $-0.36 est+20.3%
Q1 2025$-0.35 vs $-0.45 est+22.5%
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Day One Biopharmaceuticals Inc
Weekly undervalued picks (like DAWN)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.